Search Results

There are 41870 results for: content related to: Voltage-Dependent Ca2+ Channels in Small Cell Carcinomas Are Blocked by Autoantibodies from Patients with Lambert-Eaton Myasthenic Syndrome a

  1. Cloning and characterization of a lambert-eaton myasthenic syndrome antigen

    Annals of Neurology

    Volume 33, Issue 1, January 1993, Pages: 113–120, Myrna R. Rosenfeld, Ellen Wong, Josep Dalmau, Geoff Manley, Jerome B. Ponser, Emanuele Sher and Dr. Henry M. Furneaux

    Version of Record online : 8 OCT 2004, DOI: 10.1002/ana.410330126

  2. SUBJECT INDEX

    Annals of the New York Academy of Sciences

    Volume 634, Issue 1, December 1992, Pages: 181–577,

    Version of Record online : 23 DEC 2015, DOI: 10.1111/j.1749-6632.1992.tb00009.x

  3. Calcium channel autoantibodies in the lambert-eaton myasthenic syndrome

    Annals of Neurology

    Volume 29, Issue 3, March 1991, Pages: 307–314, Katherine Leysm, Dr Bethan Lang, Irene Johnston and John Newsom-Davis

    Version of Record online : 8 OCT 2004, DOI: 10.1002/ana.410290313

  4. Lambert–Eaton syndrome antibodies target multiple subunits of voltage-gated Ca2+ channels

    Muscle & Nerve

    Volume 51, Issue 2, February 2015, Pages: 176–184, Ravindra K. Hajela, Kristin M. Huntoon and William D. Atchison

    Version of Record online : 23 DEC 2014, DOI: 10.1002/mus.24295

  5. You have free access to this content
    Lambert-Eaton syndrome antibodies inhibit acetylcholine release and P/Q-type Ca2+ channels in electric ray nerve endings

    The Journal of Physiology

    Volume 508, Issue 2, April 1998, Pages: 427–438, Yasushi Satoh, Naohide Hirashima, Hiroshi Tokumaru, Masanori P. Takahashi, Jin K Ang, Michael P. Viglione, Yong I. Kim and Yutaka Kirino

    Version of Record online : 22 SEP 2004, DOI: 10.1111/j.1469-7793.1998.427bq.x

  6. Lambert-Eaton myasthenic syndrome: Clinical diagnosis, immune-mediated mechanisms, and update on therapies

    Annals of Neurology

    Volume 37, Issue S1, May 1995, Pages: 63–73, Dr Donald B. Sanders

    Version of Record online : 8 OCT 2004, DOI: 10.1002/ana.410370708

  7. Therapeutic apheresis in neurological disorders

    Journal of Clinical Apheresis

    Volume 15, Issue 1-2, 2000, Pages: 74–128, Robert Weinstein

    Version of Record online : 29 MAR 2000, DOI: 10.1002/(SICI)1098-1101(2000)15:1/2<74::AID-JCA6>3.0.CO;2-O

  8. Treatment for Lambert-Eaton myasthenic syndrome

    Intervention Review

    The Cochrane Library

    Michael Keogh, Saam Sedehizadeh and Paul Maddison

    Published Online : 16 FEB 2011, DOI: 10.1002/14651858.CD003279.pub3

  9. Immunogenicity of P/Q-type calcium channel in small cell lung cancer: investigation of α1 subunit polyglutamine expansion

    Tissue Antigens

    Volume 54, Issue 6, December 1999, Pages: 592–596, J.L. Black, T.R. Nelson, K. Snow and V.A. Lennon

    Version of Record online : 5 JAN 2002, DOI: 10.1034/j.1399-0039.1999.540609.x

  10. Autoimmune Myasthenic Syndromes: Myasthenia Gravis and Lambert–Eaton Myasthenic Syndrome

    Neuroimmunology in Clinical Practice

    Thomas H. Brannagan, Andrew Sylvester, Armistead Williams, Pages: 153–168, 2008

    Published Online : 15 APR 2008, DOI: 10.1002/9780470692363.ch9

  11. You have free access to this content
    Non-paraneoplastic Lambert–Eaton myasthenic syndrome presenting dropped head and respiratory failure with normoreflexia

    Neurology and Clinical Neuroscience

    Volume 3, Issue 5, September 2015, Pages: 188–189, Kensuke Ikeda, Hiroshi Kuroda, Hiroya Ono, Emiko Miura, Naoki Suzuki, Tatsuro Misu, Masakatsu Motomura and Masashi Aoki

    Version of Record online : 5 MAR 2015, DOI: 10.1111/ncn3.177

  12. Practical aspects of 3,4-diaminopyridine treatment of the Lambert-Eaton myasthenic syndrome

    Acta Neurologica Scandinavica

    Volume 88, Issue 2, August 1993, Pages: 136–140, H. Lundh, O. Nilsson, I. Rosén and S. Johansson

    Version of Record online : 29 JAN 2009, DOI: 10.1111/j.1600-0404.1993.tb04205.x

  13. Effect of 3,4-diaminopyridine on the time course of decay of compound muscle action potential augmentation in the Lambert–Eaton myasthenic syndrome

    Muscle & Nerve

    Volume 21, Issue 9, September 1998, Pages: 1196–1198, Paul Maddison, John Newsom-Davis and Kerry R. Mills

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1097-4598(199809)21:9<1196::AID-MUS11>3.0.CO;2-Q

  14. Stimulated single-fiber electromyography in Lambert-Eaton myasthenic syndrome before and after 3,4-diaminopyridine

    Muscle & Nerve

    Volume 20, Issue 6, June 1997, Pages: 735–739, Menachem Sadeh, Yaron River and Zohar Argov

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1097-4598(199706)20:6<735::AID-MUS11>3.0.CO;2-T

  15. Selected IgG rapidly induces Lambert–Eaton myasthenic syndrome in mice: Complement independence and EMG abnormalities

    Muscle & Nerve

    Volume 11, Issue 11, November 1988, Pages: 1133–1145, Dr. Edward H. Lambert and Dr. Vanda A. Lennon

    Version of Record online : 13 OCT 2004, DOI: 10.1002/mus.880111105

  16. Stimulated single-fiber electromyography in lambert-eaton myasthenic syndrome

    Muscle & Nerve

    Volume 14, Issue 12, December 1991, Pages: 1227–1230, Dr. Vinay Chaudhry, Dr., MD, PhD Danny F. Watson, Dr., MD Shawn J. Bird and MD David R. Cornblath

    Version of Record online : 13 OCT 2004, DOI: 10.1002/mus.880141215

  17. Antigens Associated with N- and L-Type Calcium Channels in Lambert-Eaton Myasthenic Syndrome

    Journal of Neurochemistry

    Volume 64, Issue 4, April 1995, Pages: 1696–1702, Oussama El Far, Béatrice Marquèze, Christian Leveque, Nicole Martin-Moutôt, Bethan Lang, John Newsom-Davis, Akira Yoshida, Masami Takahashi and Michael J. Seagar

    Version of Record online : 23 NOV 2002, DOI: 10.1046/j.1471-4159.1995.64041696.x

  18. Treatment in Lambert–Eaton myasthenic syndrome

    Annals of the New York Academy of Sciences

    Volume 1275, Issue 1, December 2012, Pages: 78–84, Paul Maddison

    Version of Record online : 20 DEC 2012, DOI: 10.1111/j.1749-6632.2012.06769.x

  19. You have free access to this content
    Complete reversal of Lambert–Eaton myasthenic syndrome synaptic impairment by the combined use of a K+ channel blocker and a Ca2+ channel agonist

    The Journal of Physiology

    Volume 592, Issue 16, 15 August 2014, Pages: 3687–3696, Tyler B. Tarr, David Lacomis, Stephen W. Reddel, Mary Liang, Guillermo Valdomir, Michael Frasso, Peter Wipf and Stephen D. Meriney

    Version of Record online : 16 JUL 2014, DOI: 10.1113/jphysiol.2014.276493

  20. Transient Lambert-Eaton myasthenic syndrome associated with systemic lupus erythematosus

    Muscle & Nerve

    Volume 12, Issue 1, January 1989, Pages: 15–19, Dr. Mark B. Bromberg, James W. Albers and Dr. W. Joseph McCune

    Version of Record online : 13 OCT 2004, DOI: 10.1002/mus.880120104